JE Cleantech Holdings Ltd financial statements

Income statement, balance sheet and cash flow statement for the last 5 fiscal years, taken from the XBRL data JE Cleantech Holdings Ltd files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	10.9	13.9	13.7	14.1	15.8
Cost of revenue	9.18	10.1	10.4	10.3	11.3
Gross profit	1.74	3.83	3.31	3.8	4.49
Selling and marketing	0.02	0.02	0.04	0.09	0.1
General and administrative	1.68	2.49	2.5	3.73	3.92
Operating expenses	1.69	2.51	2.54	3.82	4.02
Operating income	0.04	1.32	0.77	-0.02	0.48
Interest income				0.14	0.11
Other non-operating income	-0.04	-0.25	-0.29	0.23	2.16
Pre-tax income	0	1.06	0.48	0.21	2.64
Income tax		0.18	0.08	0.18	0.12
Net income	0	0.89	0.39	0.03	2.52
EBITDA	0.5	1.82	1.3	0.54	1.02
EPS, basic	0.00	0.06	0.08	0.00	0.48
EPS, diluted	0.00	0.06	0.08	0.00	0.48
Shares, basic (weighted)	4,000	4.7	5.01	5.31	5.31
Shares, diluted (weighted)	4,000	4.7	5.01	5.31	5.31

Balance sheet

	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	0.82	4.9	3.86	4.2	7.72
Receivables	2.38	4.2	3.62	3.29	5.76
Inventory	1.89	8.87	10.7	9.26	7.16
Other current assets	0.62	1.68	1.79	1.79	0.65
Total current assets	5.72	19.6	20.2	18.8	21.3
Property, plant and equipment	6.64	6.58	6.45	2.97	2.91
Lease right-of-use assets				1.2	0.76
Other non-current assets				0.09	0.04
Total assets	13.6	26.5	26.9	25.7	25.7
Deferred revenue		3.27	5.09	5.18	4.52
Total current liabilities	6.99	10.3	10.4	7.37	7.82
Lease liabilities	1.03	1.05	0.97	0.72	0.03
Total liabilities	11.4	14.3	14.2	13.6	10.3
Paid-in capital	2.68	11.7	11.9	11.4	12.1
Retained earnings	-0.43	0.45	0.85	0.85	3.42
Treasury stock			-0.01	-0.05	-0.06
Other comprehensive income	-0.03	-0.02	-0.08	-0.1	-0.06
Shareholders' equity	2.24	12.1	12.7	12.1	15.4
Total equity	2.24	12.1	12.7	12.1	15.4
Total liabilities and equity	13.6	26.5	26.9	25.7	25.7
Shares outstanding	12	5.01	5.01	0	0

Cash flow statement

	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	0	0.89	0.39	0.03	2.52
Depreciation and amortization	0.45	0.5	0.53	0.56	0.54
Deferred income tax			0.01	-0.07	0.03
Change in receivables	4.1	-1.86	0.57	0.01	-0.96
Change in inventory	-0.87	-6.96	-1.65	1.05	2.68
Cash from operations	2.49	-3.91	1.04	1.5	2.09
Capital expenditures	-0.58	-0.61	-0.16	-0.92	-0.65
Cash from investing	-0.53	-0.6	-0.16	-1.09	4.89
Stock issued		11.1
Dividends paid	-2.15			-0.47
Cash from financing	-1.54	8.57	-1.95	0.09	-3.76
Net change in cash	0.41	4.07	-1.12	0.48	3.26
Free cash flow	1.91	-4.52	0.88	0.59	1.45
Interest paid	0.16	0.24	0.39	0.38	0.32
Income taxes paid	0.39		0.22	0.15	0.06

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $1.43 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	28.5%	Gross profit / revenue.
Operating margin	3.0%	Operating income / revenue.
EBITDA margin	6.5%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	16.7%	Pre-tax income / revenue.
Net margin	15.9%	Net income / revenue.
FCF margin	9.2%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	13.2%	Cash from operations / revenue.
Effective tax rate	4.6%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	18.3%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	9.8%	Net income / average total assets.
Return on invested capital (ROIC)	5.8%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Capex / revenue	4.1%	Capital expenditures / revenue.
D&A / revenue	3.4%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	11.8%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	4.3%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y	18.2%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	5.5%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 3y	-28.8%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y	88.0%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-17.5%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y	9,968.0%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	41.5%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 3y	100.0%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	39.1%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y	146.8%	Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	27.4%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	8.2%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y	-0.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-1.0%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y	0.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	4.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.72x	Current assets / current liabilities.
Quick ratio	1.72x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.99x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	40.1%	Total liabilities / total assets.
Working capital	$13.5M	Current assets - current liabilities.
Tangible book value	$15.4M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.61x	Revenue / average total assets.
Fixed asset turnover	5.37x	Revenue / average property, plant and equipment.
Inventory turnover	1.38x	Cost of revenue / average inventory.
Days inventory	265 days	365 x average inventory / cost of revenue.
Receivables turnover	3.49x	Revenue / average receivables.
Days sales outstanding	105 days	365 x average receivables / revenue.
FCF conversion	57.4%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	30.8%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.48	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	$0.48	Net income per basic share, as reported (split-adjusted).
Revenue per share	$2.97	Revenue / diluted weighted shares.
FCF per share	$0.27	Free cash flow / diluted weighted shares.
Operating cash flow per share	$0.39	Cash from operations / diluted weighted shares.

Valuation

Metric	Value	How it is calculated
Market cap	$7.5M	Share price x shares outstanding.
Enterprise value	-$211.6K	Market cap + total debt - cash - short-term investments.
P/E	2.98x	Market cap / net income. Only when net income is positive.
P/S	0.48x	Market cap / revenue.
P/B	0.49x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	0.49x	Market cap / tangible book value, when positive.
P/FCF	5.19x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	3.59x	Market cap / cash from operations, when positive.
FCF yield	19.3%	Free cash flow / market cap.
Earnings yield	33.5%	Net income / market cap (the inverse of P/E).
PEG	0.03x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was JE Cleantech Holdings Ltd's revenue in fiscal 2025?

JE Cleantech Holdings Ltd reported revenue of $15.8M for fiscal 2025, 11.8% higher than the year before.

Was JE Cleantech Holdings Ltd profitable in fiscal 2025?

Yes. Net income was $2.5M, a net margin of 15.9%.

How much free cash flow did JE Cleantech Holdings Ltd generate in fiscal 2025?

Cash from operations of $2.1M minus capital expenditures of $645.0K left free cash flow of $1.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to JE Cleantech Holdings Ltd